Apollo Hospitals Enterprise Limited

As of June 30, 2026, Apollo Hospitals Enterprise Limited carries a market capitalization of 1.25T, placing it among publicly traded companies globally. Its enterprise value stands at 1.25T, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Apollo Hospitals Enterprise Limited's next confirmed earnings release is scheduled for November 4, 2026.

As of June 30, 2026, Apollo Hospitals Enterprise Limited has 143.78M shares outstanding.

As of June 30, 2026, Apollo Hospitals Enterprise Limited trades at a trailing price-to-earnings ratio of 61.03.

As of June 30, 2026, Apollo Hospitals Enterprise Limited trades at an EV/EBITDA multiple of 32.00 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 4.81 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 41.50 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 1.25T versus a market cap of 1.25T, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 6.00M in revenue per employee across its workforce of 43,252.50, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Apollo Hospitals Enterprise Limited recorded 6.66B in income tax expense. That works out to an effective tax rate of 23.91, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 27.85B, leaving 20.45B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 23, 2026, Apollo Hospitals Enterprise Limited's stock has declined approximately 3.30% over the past 52 weeks. The 50-day moving average sits at 8,497.08, while the 200-day moving average is 8,072.98.

Over the twelve months ended June 30, 2026, Apollo Hospitals Enterprise Limited generated 259.69B in revenue and converted that into 20.45B in net income, yielding earnings per share of 147.31. EBITDA reached 39.01B, while operating income came in at 30.27B.

Over the twelve months ended June 30, 2026, Apollo Hospitals Enterprise Limited posted a gross margin of 48.29, reflecting its pricing power and cost economics. The operating margin of 11.66 and net profit margin of 7.88 provide insight into operational efficiency.

Apollo Hospitals Enterprise Limited's most recent stock split took place on September 2, 2010 with a 1:2 split ratio.